RemeGen Co., Ltd.
REGMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $87 | $572 | $526 | $508 |
| % Growth | -84.8% | 8.7% | 3.5% | – |
| Cost of Goods Sold | $13 | $87 | $88 | $102 |
| Gross Profit | $73 | $485 | $438 | $406 |
| % Margin | 84.5% | 84.8% | 83.3% | 79.9% |
| R&D Expenses | $34 | $318 | $329 | $403 |
| G&A Expenses | $0 | $56 | $90 | $82 |
| SG&A Expenses | $52 | $334 | $336 | $407 |
| Sales & Mktg Exp. | $0 | $275 | $251 | $326 |
| Other Operating Expenses | $0 | $24 | $22 | -$4 |
| Operating Expenses | $86 | $676 | $688 | $806 |
| Operating Income | -$13 | -$191 | -$250 | -$400 |
| % Margin | -15.1% | -33.5% | -47.5% | -78.7% |
| Other Income/Exp. Net | -$1 | -$4 | -$4 | $3 |
| Pre-Tax Income | -$14 | -$195 | -$254 | -$397 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14 | -$195 | -$254 | -$397 |
| % Margin | -16.4% | -34.2% | -48.3% | -78.1% |
| EPS | -0.025 | -0.37 | -0.46 | -0.74 |
| % Growth | 93.2% | 19.6% | 37.8% | – |
| EPS Diluted | -0.025 | -0.37 | -0.46 | -0.74 |
| Weighted Avg Shares Out | 562 | 531 | 552 | 536 |
| Weighted Avg Shares Out Dil | 562 | 531 | 552 | 536 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $20 | $20 | $16 |
| Depreciation & Amortization | $0 | $63 | $58 | $58 |
| EBITDA | -$12 | -$105 | -$169 | -$329 |
| % Margin | -14% | -18.4% | -32.2% | -64.7% |